Reporting owner · Q3 2026 · CIK 2148128

Forbion Ventures Fund VII Cooperatief U.A.: insider trades.

Forbion Ventures Fund VII Cooperatief U.A. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($64.8M) and 0 sales, across 1 company.

Transactions
4
Purchases (P)
2
Sales (S)
0
Companies
1
Name as filed
Forbion Ventures Fund VII Cooperatief U.A.

Companies

CompanyRelationshipTransactions
Braveheart Bio, Inc. (BRVE)TenPercentOwner4

Transactions

4 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-08-07Braveheart Bio, Inc.C9,132,420$09,720,546Form 4
2026-08-07Braveheart Bio, Inc.P1,680,000$1810,185,478Form 4
2026-08-07Braveheart Bio, Inc.P1,920,000$1811,640,546Form 4
2026-08-07Braveheart Bio, Inc.C7,990,867$08,505,478Form 4

Questions

What stock did Forbion Ventures Fund VII Cooperatief U.A. buy or sell?

Forbion Ventures Fund VII Cooperatief U.A. reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($64.8M) and 0 sales, across 1 company.

Is Forbion Ventures Fund VII Cooperatief U.A. the same person as other filers with this name?

This page covers SEC CIK 2148128 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/forbion-ventures-fund-vii-cooperatief-u-a-2148128.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.